Skip to main content

Table 1 Population

From: Infusion-related thrombogenesis by liver-derived mesenchymal stem cells controlled by anticoagulant drugs in 11 patients with liver-based metabolic disorders

 Number of patients
Infused patients11
  Type 15
  Type 21
 Urea cycle defect5
  OTC deficiency4
  Arginase deficiency1
Age at infusion0.9–16.25 year(s)
Patients per cell dosage
 12.5 × 106/kg4
 50 × 106/kg2
 200 × 106/kg5
Total number of infusions1–10
Total number of days of infusions1–4
Completed infusion cycles7